Predicting the effectiveness of the Finnish population-based colorectal cancer screening programme

被引:6
作者
Chiu, Sherry Yueh-Hsia [1 ,2 ]
Malila, Nea [3 ,4 ]
Yen, Amy Ming-Fang [5 ]
Chen, Sam Li-Sheng [5 ]
Fann, Jean Ching-Yuan [6 ]
Hakama, Matti [3 ,4 ]
机构
[1] Chang Gung Univ, Dept Hlth Care Management, Tao Yuan, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan
[3] Univ Tampere, Sch Hlth Sci, Tampere, Finland
[4] Canc Soc Finland, Finnish Canc Registry, Helsinki, Finland
[5] Taipei Med Univ, Sch Oral Hyg, Taipei, Taiwan
[6] Kainan Univ, Dept Hlth Ind Management, Tao Yuan, Taiwan
基金
芬兰科学院;
关键词
Colorectal cancer screening; population-based; effectiveness; natural history; RANDOMIZED CONTROLLED-TRIAL; OCCULT BLOOD-TEST; SOJOURN TIME; SENSITIVITY; PARAMETERS; INTERVAL; SEX;
D O I
10.1177/0969141316684524
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Because colorectal cancer (CRC) has a long natural history, estimating the effectiveness of CRC screening programmes requires long-term follow-up. As an alternative, we here demonstrate the use of a temporal multi-state natural history model to predict the effectiveness of CRC screening. Methods: In the Finnish population-based biennial CRC screening programme using faecal occult blood tests (FOBT), which was conducted in a randomised health services study, we estimated the pre-clinical incidence, the mean sojourn time (MST), and the sensitivity of FOBT using a Markov model to analyse data from 2004 to 2007. These estimates were applied to predict, through simulation, the effects of five rounds of screening on the relative rate of reducing advanced CRC with 6 years of follow-up, and on the reduction in mortality with 10 years of follow-up, in a cohort of 500,000 subjects aged 60 to 69. Results: For localised and non-localised CRC, respectively, the MST was 2.06 and 1.36 years and the sensitivity estimates were 65.12% and 73.70%. The predicted relative risk of non-localised CRC and death from CRC in the screened compared with the control population was 0.86 (95% CI: 0.79-0.98) and 0.91 (95% CI: 0.85-1.02), respectively. Conclusion: Based on the preliminary results of the Finnish CRC screening programme, our model predicted a 9% reduction in CRC mortality and a 14% reduction in advanced CRC.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 23 条
  • [1] Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database
    Brenner, Hermann
    Altenhofen, Lutz
    Katalinic, Alexander
    Lansdorp-Vogelaar, Iris
    Hoffmeister, Michael
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (10) : 1140 - 1146
  • [2] Chen HH, 1996, J ROY STAT SOC D-STA, V45, P307
  • [3] Estimation of sojourn time in chronic disease screening without data on interval cases
    Chen, THH
    Kuo, HS
    Yen, MF
    Lai, MS
    Tabar, L
    Duffy, SW
    [J]. BIOMETRICS, 2000, 56 (01) : 167 - 172
  • [4] Analytical decision model for sample size and effectiveness projections for use in planning a population-based randomized controlled trial of colorectal cancer screening
    Chiu, Sherry Y-H
    Malila, Nea
    Yen, Amy M-F
    Anttila, Ahti
    Hakama, Matti
    Chen, H-H
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2011, 17 (01) : 123 - 129
  • [5] ESTIMATING THE SENSITIVITY OF A SCREENING-TEST
    DAY, NE
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1985, 39 (04) : 364 - 366
  • [6] Analysis of screening data: Colorectal cancer
    Gyrd-Hansen, D
    Sogaard, J
    Kronborg, O
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (06) : 1172 - 1181
  • [7] Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre-invasive phase
    Hakama, Matti
    Pokhrel, Arun
    Malila, Nea
    Hakulinen, Timo
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (04) : 928 - 935
  • [8] Randomised health services studies
    Hakama, Matti
    Malila, Nea
    Dillner, Joakim
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (12) : 2898 - 2902
  • [9] Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
    Hardcastle, JD
    Chamberlain, JO
    Robinson, MHE
    Moss, SM
    Amar, SS
    Balfour, TW
    James, PD
    Mangham, CM
    [J]. LANCET, 1996, 348 (9040) : 1472 - 1477
  • [10] Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening
    Jouve, JL
    Remontet, L
    Dancourt, V
    Lejeune, C
    Benhamiche, AM
    Faivre, J
    Esteve, J
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (11) : 1477 - 1481